Thus, Ctip inactivation inhibits the formation of mammary tumors caused by either homozygous or heterozygous p53 gene inactivation (Figure 4) or by a dominant-negative p53 missense mutation frequently observed in human breast cancer (Figure 6). Here, RBBP8 is linked to breast cancer.